pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
EDV-2209
Subarachnoid Hemorrhage
Edvince AB
0
catalysts
Phase 2
EEDVD-682
Pancreatic Ductal Adenocarcinoma
EnGeneIC Ltd
0
catalysts
Phase 2
EF-001
Anaplastic Astrocytoma
Everfront Biotech Inc
0
catalysts
Preclinical
EF-005
Alzheimer's Disease
Everfront Biotech Inc
← prev
page 89 of 271
next →
131
Pain
89
Neurology
1
0
catalysts
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)
CIPLA
0
catalysts
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE (EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE)
LAURUS
0
catalysts
Phase 1
EG-001
Idiopathic Interstitial Pneumonia (IIP)
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Phase 2
EG-007
Endometrial Cancer
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Phase 1
EG-009
Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-102
Focal Segmental Glomerulosclerosis (FSGS)
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Phase 2
EG-110A
Neurogenic Bladder Dysfunction
EG 427
0
catalysts
Preclinical
EG-201
Wet (Neovascular / Exudative) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Phase 1
EG-301
Dry (Atrophic) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-401
Diabetic Retinopathy
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-402
Retinopathy Of Prematurity
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Phase 2
EG-501
Cognitive Impairment
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-Mirotin
Diabetic Retinopathy
EyeGene Inc
0
catalysts
Phase 2
EGT-101
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Esteve Pharmaceuticals SA
0
catalysts
Preclinical
EGT-201
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Esteve Pharmaceuticals SA
0
catalysts
Preclinical
EGT-301
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Esteve Pharmaceuticals SA
0
catalysts
Phase 2
EH-301
Amyotrophic Lateral Sclerosis
Elysium Health Inc
0
catalysts
Preclinical
EIR-0205
Dry (Atrophic) Macular Degeneration
EIR Biopharma Inc
0
catalysts
Preclinical
EIR-1003
Neovascular Glaucoma
EIR Biopharma Inc
0
catalysts
Phase 2
EIS-12656
Breast Cancer
Eisbach Bio GmbH
0
catalysts
Preclinical
EKZ-102
Parkinson's Disease
Eikonizo Therapeutics Inc
0
catalysts
Preclinical
EL-100
Critical Limb Ischemia
Elphis Cell Therapeutics Co Ltd
0
catalysts
Phase 1
EL-22
Obesity
Northstrive Biosciences Inc
0
catalysts
ELELYSO
ELELYSO (TALIGLUCERASE ALFA)
1 INDICATIONS AND USAGE ELELYSO is indicated for the treatment of patients 4…
$PFE
PFIZER INC
0
catalysts
Phase 2
ELI-002 2P
Colorectal Cancer
$ELTX
Elicio Therapeutics, Inc.
0
catalysts
ELLIOTTS B
ELLIOTTS B (SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE)
LUKARE MEDICAL LLC
0
catalysts
